Disposition of loratadine in healthy volunteers

References

• Agrawal DK. Pharmacology and clinical efficacy of desloratadine as an anti-allergic and anti-inflammatory drug. Expert Opinion on Investigational Drugs 2001; 10: 547–560
   PubMed Web of Science ®Google Scholar
• Bignan GC, McNamara P, Lee JI. Synthesis of labeled piperidines: Application toward the synthesis of deuterated loratadine and desloratadine. Book of Abstracts, 218th ACS National Meeting. New Orleans 22–26 August, 1999, ORGN-477
   Google Scholar
• Chowdhury SK, Alvarez N, Su AD, Ramanathan R, Feng W, Aslanian R, Alton KB, Patrick JE. Identification of a novel metabolic pathway in the metabolism of desloratadine in rats. Proceedings of the 49th ASMS Conference on Mass Spectrometry and Allied Topics. Chicago, IL USA 2001
   Google Scholar
• Dresser GK, Spence JD, Bailey DG. Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition. Clinical Pharmacokinetics 2000; 38: 41–57
   PubMed Web of Science ®Google Scholar
• Geha RS, Meltzer EO. Desloratadine: A new, nonsedating, oral antihistamine. Journal of Allergy Clinical Immunology 2001; 107: 751–762
   PubMed Web of Science ®Google Scholar
• Ghosal A, Gupta S, Chowdhury S, Yuan Y, Lu X, Horne D, Su A, Alvarez N, Ramanathan R, Hanna I, et al. Identification of human cytochrome P450 enzymes that metabolize loratadine (LOR). Drug Metabolism Reviews 2003; 38: 111
   Google Scholar
• Haria M, Fitton A, Peters DH. Loratadine. A reappraisal of its pharmacological properties and therapeutic use in allergic disorders. Drugs 1994; 48: 617–637
   PubMed Web of Science ®Google Scholar
• Henz BM. The pharmacologic profile of desloratadine: A review. Allergy 2001; 56(Suppl 65)7–13
   PubMed Web of Science ®Google Scholar
• Hilbert J, Radwanski E, Weglein R, Luc V, Perentesis G, Symchowicz S, Zampaglione N. Pharmacokinetics and dose proportionality of loratadine. Journal of Clinical Pharmacology 1987; 27: 694–698
   PubMed Web of Science ®Google Scholar
• Kane GC, Lipsky JJ. Drug–grapefruit juice interactions. Mayo Clinic Proceedings 2000; 75: 933–942
   PubMed Web of Science ®Google Scholar
• Katchen B, Cramer JMC, Gural R, Hilbert J, Luc V, Mortizen V, D'Souza R, Symchowicz S, Zamaglione N. Disposition of 14C-SCH 29851 in human. Ann Allerg 1985; 55: 393
   Google Scholar
• Kay GG, Harris AG. Loratadine: A nonsedating antihistamine. Review of its effects on cognition, psychomotor performance, mood and sedation. Clinical and Experimental Allergy 1999; 29: 147–150
   PubMed Web of Science ®Google Scholar
• Masse FX, Miller T. Exposure to radiation informed consent. IRB 1985; 7: 1–4
   PubMedGoogle Scholar
• Mattila MJ, Paakkari I. Variations among non-sedating antihistamines: Are there real differences?. European Journal of Clinical Pharmacology 1999; 55: 85–93
   PubMedGoogle Scholar
• Perrier D, Gibaldi M. General derivation of the equation for time to reach a certain fraction of steady state. Journal of Pharmaceutical Sciences 1982; 71: 474–475
   PubMed Web of Science ®Google Scholar
• Philpot EE. Safety of second-generation antihistamines. Allergy and Asthma Proceedings 2000; 21: 15–20
   PubMed Web of Science ®Google Scholar
• Piwinski JJ, Wong JK, Chan TM, Green MJ, Ganguly AK. Hydroxylated metabolites of loratadine: An example of conformational diastereomers due to atropisomerism. Journal of Organic Chemistry 1990; 55: 3341–3350
   Web of Science ®Google Scholar
• Ramanathan R, Su AD, Alvarez N, Blumenkrantz N, Chowdhury SK, Alton K, Patrick J. Liquid chromatography/mass spectrometry methods for distinguishing N-oxides from hydroxylated compounds. Analytical Chemistry 2000; 72: 1352–1359
   PubMed Web of Science ®Google Scholar
• Ramanathan R, Alvarez N, Su AD, Chowdhury S, Alton K, Stauber K, Patrick J. Metabolism and excretion of loratadine in male and female mice, rats and monkeys. Xenobiotica 2005a; 35: 155–189
   PubMed Web of Science ®Google Scholar
• Ramanathan R, Chowdhury SK, Alton KB. Oxidative metabolites of drugs and xenobiotics: LC-MS methods to identify and characterize in biological matrices. Identification and quantification of drugs, metabolites and metabolizing enzymes by LC-MS., SK Chowdhury. Elsevier, San Diego, CA 2005b
   Google Scholar
• Renwick AG. The metabolism of antihistamines and drug interactions: The role of cytochrome P450 enzymes. Clinical and Experimental Allergy 1999; 29: 116–124
   PubMedGoogle Scholar
• Simons FE, Simons KJ. Clinical pharmacology of new histamine H1 receptor antagonists. Clinical Pharmacokinetics 1999; 36: 329–352
   PubMed Web of Science ®Google Scholar
• Slater JW, Zechnich AD, Haxby DG. Second-generation antihistamines: A comparative review. Drugs 1999; 57: 31–47
   PubMed Web of Science ®Google Scholar
• Soldner A, Christians U, Susanto M, Wacher VJ, Silverman JA, Benet LZ. Grapefruit juice activates P-glycoprotein-mediated drug transport. Pharmaceutical Research 1999; 16: 478–485
   PubMed Web of Science ®Google Scholar
• Sutherland FC, de Jager AD, Badenhorst D, Scanes T, Hundt HK, Swart KJ, Hundt AF. Sensitive liquid chromatography-tandem mass spectrometry method for the determination of loratadine and its major active metabolite descarboethoxyloratadine in human plasma. Journal of Chromatography. A 2001; 914: 37–43
   PubMed Web of Science ®Google Scholar
• Trygstad TK, Hansen RA, Wegner SE. Evaluation of product switching after a state Medicaid program began covering loratadine OTC 1 year after market availability. Journal of Managed Care Pharmacy 2006; 12: 108–120
   PubMed Web of Science ®Google Scholar
• Walsh GM, Annunziato L, Frossard N, Knol K, Levander S, Nicolas JM, Taglialatela M, Tharp MD, Tillement JP, Timmerman H. New insights into the second generation antihistamines. Drugs 2001; 61: 207–236
   PubMed Web of Science ®Google Scholar
• Wang E-J, Casciano CN, Clement RP, Johnson WW. Evaluation of the interaction of loratadine and desloratadine with P-glycoprotein. Drug Metabolism and Disposition 2001; 29: 1080–1083
   PubMed Web of Science ®Google Scholar
• Yumbie N, Huie K, Chen KJ, Snow M, Clement RP, Cayen MN. Identification of human liver cytochrome P450 enzymes that metabolize the nonsedating antihistamine loratadine. Biochemical Phramacology 1995; 51: 165–172
   PubMedGoogle Scholar
• Zhang Y, Benet LZ. The gut as a barrier to drug absorption: Combined role of cytochrome P450 3A and P-glycoprotein. Clinical Pharmacokinetics 2001; 40: 159–168
   PubMed Web of Science ®Google Scholar